Creative Planning Unity Biotechnology, Inc. Transaction History

Creative Planning

  • $101 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 03, 2022
BUY
$0.4 - $4.27 $2,400 - $25,619
6,000 Added 24.21%
30,788 $12,000
Q2 2022

Aug 15, 2022
BUY
$0.56 - $1.29 $7,672 - $17,673
13,700 Added 123.56%
24,788 $14,000
Q1 2022

May 16, 2022
BUY
$0.72 - $1.86 $7,983 - $20,623
11,088 New
11,088 $12,000

Others Institutions Holding UBX

# of Institutions
1
Shares Held
4.41M
Call Options Held
0
Put Options Held
0
View Full List

About Unity Biotechnology, Inc.

UBX Quotes by TradingView
  • Ticker UBX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,036,200
  • Market Cap $16.1M
  • Description
  • Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...
More about UBX
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email